New approach tested for lingering lyme disease misery
NCT ID NCT06785402
Summary
This early-phase study is testing whether giving the antibiotic ceftriaxone in pulses (once every five days for about six weeks) can help people with persistent symptoms after Lyme disease treatment. Twenty participants will be randomly assigned to receive either the antibiotic or a placebo via IV, with follow-up for a full year. The main goals are to check if this schedule is safe and tolerable, and to see if it reduces symptoms like fatigue and pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TREATMENT LYME DISEASE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.